← Leaderboards
Daesung Shin
State University Of New York At Buffalo
$2,365,315
Attributed
$2,365,315
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $411.6K · FY2014–25$500K$375K$250K$125K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,365,315 · 3
By mechanism
R01$1,807,273 · 1
R56$398,750 · 1
R03$159,292 · 1
Top collaborators
No co-investigators on record.
Most similar at State University Of New York At Buffalo
Same institution · by research overlap
- Pablo Martin Paez$3,446,630
- Kenneth R Hoffmann$2,606,349
- Nadav Weinstock$143,162
- Randolph Lee Carter$219,313
- Narayan Dhimal$62,490
Others in their field
Top investigators on “Phenotype”
- David R. Weir · University Of Michigan At Ann Arbor$239,033,262
- David Heimbrook · Leidos Biomedical Research, Inc.$213,586,034
- Constance Ann Benson · University Of California, San Diego$187,132,366
- Richard A Gibbs · Baylor College Of Medicine$184,906,270
- James E. Gern · University Of Wisconsin-Madison$141,704,104
- Garret A Fitzgerald · University Of Pennsylvania$141,348,491
Research focus
PhenotypeSymptomsNerve DegenerationPathologyMutationPsychosineDemyelinationsMouse ModelNeurologicOligodendrogliaDesignBrain CellAffectEnzymesAttenuatedBrainCause Of DeathGloboid Cell LeukodystrophyMicrogliaCell TypeCellsInfancyCessation Of LifeEffective Therapy
Grant awards (8)
Selective galactosylceramidase ablation to study the pathogenesis of Krabbe leukodystrophy$411,649
R01 · FY2025 · NS · contact PI
Selective Galactosylceramidase Ablation to Study the Pathogenesis of Krabbe Leukodystrophy$348,906
R01 · FY2023 · NS · contact PI
Selective galactosylceramidase ablation to study the pathogenesis of Krabbe leukodystrophy$348,906
R01 · FY2022 · NS · contact PI
Selective galactosylceramidase ablation to study the pathogenesis of Krabbe leukodystrophy$348,906
R01 · FY2021 · NS · contact PI
Selective galactosylceramidase ablation to study the pathogenesis of Krabbe leukodystrophy$348,906
R01 · FY2020 · NS · contact PI
Selective galactosylceramidase ablation to study the pathogenesis of Krabbe leukodystrophy$398,750
R56 · FY2019 · NS · contact PI
Clinical variability and Cell autonomy of Krabbe leukodystrophy$79,750
R03 · FY2015 · NS · contact PI
Clinical variability and Cell autonomy of Krabbe leukodystrophy$79,542
R03 · FY2014 · NS · contact PI